Dr Reddys Lab settles Clarinex drug dispute; stk down
Dr Reddys Laboratories had touched an intraday high of Rs 478 and an intraday low of Rs 455. At 11:07 am, the share was quoting at Rs 456.50, down Rs 11.5, or 2.46%. The company has settled Clarinex drug dispute with Schering Corporation & Sepracor Inc, reports CNBC-TV18.